A randomized phase III trial of adjuvant chemotherapy with cisplatin and vindesine followed by UFT for completely resected pathologic (p-) stage IIIA-N2 non-small cell lung cancer (NSCLC): West Japan Study Group for Lung Cancer Surgery (WJSG) - the 5th Study

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 7262-7262 ◽  
Author(s):  
F. Tanaka ◽  
N. Tsubota ◽  
S. Namikawa ◽  
M. Ohta ◽  
M. Yamakido ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document